ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Diaper dermatitis

Diaper dermatitis
Literature review current through: Jan 2024.
This topic last updated: Feb 10, 2022.

INTRODUCTION — Diaper dermatitis, also called diaper rash, napkin dermatitis, and nappy rash, is the most common skin eruption in infants and toddlers [1-3]. It typically occurs on convex skin surfaces that are in direct contact with the diaper, including the buttocks, lower abdomen, genitalia, and upper thighs (figure 1).

Although in most cases diaper dermatitis is a form of irritant contact dermatitis, eruptions in the diaper area may represent exacerbations of more diffuse skin diseases, such as seborrheic dermatitis or atopic dermatitis, or may be the manifestation of unrelated skin conditions that coincidently manifest in the diaper area (table 1) [3,4].

The clinical features, diagnosis, treatment, and prevention of irritant diaper dermatitis will be reviewed here. Contact dermatitis, seborrheic dermatitis, and psoriasis in children are discussed separately. (See "Allergic contact dermatitis in children" and "Cradle cap and seborrheic dermatitis in infants" and "Psoriasis in children: Epidemiology, clinical manifestations, and diagnosis".)

EPIDEMIOLOGY — The reported incidence and age of onset of diaper dermatitis vary worldwide, in relation to differences in diaper use, toilet training, hygiene, and child-rearing practices in different countries [5-9]. In the United States, dermatitis of the diaper area represents 10 to 20 percent of all skin disorders evaluated by the general pediatrician [5,6,9].

According to the 1990 to 1997 National Ambulatory Medical Care Survey, there were 8.2 million pediatric visits for diaper dermatitis, and the calculated risk of developing diaper dermatitis throughout childhood was one in four [6]. In infants, the estimated prevalence of diaper dermatitis ranges from 7 to over 40 percent [6,10,11]. Diaper dermatitis can develop as early as one week of age, but the peak incidence occurs between 9 and 12 months [12,13].

PATHOGENESIS — Several factors concur in the pathogenesis of diaper dermatitis. They include excessive moisture, friction, increased pH, and high enzymatic activity, all of which contribute to the local disruption of the skin barrier function [14-16]. The normal acidic pH of the stratum corneum ("acid mantle") has an important role in the formation and maintenance of the permeability barrier and in the antimicrobial defense [17].

The increased moisture in the diaper area due to a combination of the occlusive effect of the diaper with the presence of fecal and urinary waste leads to maceration of the skin and disruption of the stratum corneum [18-20]. Maceration increases the susceptibility to frictional damage from the diaper with further impairment of the skin barrier function [3,14,21,22]. An altered skin barrier then permits increased permeation of chemical irritants and microorganisms [14,19,21,23].

The primary chemical irritants in the diaper area are derived from the synergistic action of urine and stool [24-26]. Fecal bacteria produce the enzyme urease, which interacts with urine to increase the pH level beneath the diaper [24,26]. Elevated pH levels activate fecal enzymes (protease and lipase) that directly irritate and damage the skin, causing an inflammatory skin reaction [25]. In addition, the elevated pH alters the cutaneous microbiome, making the skin more susceptible to colonization by organisms commonly found on the skin surface (eg, Staphylococcus aureus, Streptococcus pyogenes) and organisms found in the stool, such as Candida albicans [23].

RISK FACTORS — A variety of factors may increase the risk of diaper dermatitis:

Infrequent diaper changing.

Infants with diarrhea or chronic stooling have an increased risk of developing diaper dermatitis due to continuous local skin irritation [10,27,28].

Dietary factors also may play a role. Breast-fed infants have a lower incidence of diaper dermatitis than formula-fed infants, possibly because breast-fed infants have lower stool pH [24,26].

Recent use of broad-spectrum antibiotics may predispose infants to develop diaper dermatitis by increasing the risk of developing diarrhea and secondary yeast infections [29].

CLINICAL FEATURES — Irritant diaper dermatitis typically occurs on convex skin surfaces that are in direct contact with the diaper (picture 1A) [18,19]. These locations include the buttocks, lower abdomen, genitalia, and upper thighs (figure 1). The skin folds (areas not in direct contact with the diaper) are classically spared [9]. "Tidewater dermatitis" describes a pattern of erythema and scaling at the diaper margin due to friction and cycles of wetness and dryness in the affected areas [1,30].

The severity of irritant diaper dermatitis ranges from mild asymptomatic erythema to severe inflammation [2]:

Mild diaper dermatitis – Mild diaper dermatitis is characterized by scattered erythematous papules or mild asymptomatic erythema over limited skin areas with minimal maceration and frictional irritation (picture 2).

Moderate diaper dermatitis – Moderate diaper dermatitis is characterized by more extensive erythema with maceration or superficial erosions (picture 1A-C). Pain and discomfort are associated symptoms.

Severe diaper dermatitis – Severe diaper dermatitis is characterized by extensive erythema with a glossy appearance, painful erosions, papules, and nodules (picture 3A-B).

Rare presentations of severe chronic irritant diaper dermatitis that are seen in children usually older than six months and in adults with urinary or fecal incontinence include [3,31]:

Jacquet's erosive diaper dermatitis – Jacquet's erosive diaper dermatitis is characterized by well-demarcated papules, nodules, and punched-out ulcerations in the perineal region (picture 4) [32]. Factors contributing to the development of Jacquet's erosive dermatitis include urinary incontinence, infrequent diaper changing, and chronic stooling.

Granuloma gluteale infantum – Granuloma gluteale infantum presents with characteristic reddish-purple nodules in the inguinal folds, scrotum, buttocks, and medial thighs and is usually seen between two and nine months of age (picture 5) [33,34]. Numerous precipitating factors have been identified, including the use of high-potency topical corticosteroids and pre-existing candidal infections [34,35]. Although granuloma gluteale infantum may clinically resemble a neoplastic process, it is considered a benign, inflammatory dermatosis. Skin biopsy may help confirm the diagnosis. Histology shows acanthosis; hypergranulosis; and a nonspecific, dermal, inflammatory infiltrate [33,34]. It may improve with the avoidance of inciting factors and aggressive barrier protection.

Pseudoverrucous papules and nodules Pseudoverrucous papules and nodules present as multiple shiny, white-gray, wart-like papules and nodules on an erythematous background located in the genital area (picture 6) [36]. They have been reported in the peristomal area of patients with urostomy and in incontinent children and adults [37-42].

A form of irritant diaper dermatitis presenting with vesiculobullous lesions associated with cloth diapers has been reported [43].

Clinical course — The course of diaper dermatitis is typically episodic. Each episode of mild to moderate diaper dermatitis treated with conventional therapies has an average duration of two to three days. Diaper dermatitis that persists for more than three days despite standard treatment may be secondarily infected with C. albicans.

Secondary infection — If irritant dermatitis is left untreated for more than three days, it may become secondarily infected with microorganisms such as C. albicans or, less frequently, S. aureus, S. pyogenes, or herpes simplex virus [21,44]:

Candidal infectionCandida superinfection classically presents with beefy red plaques, satellite papules, and superficial pustules that leave a collarette of scale once ruptured. In contrast to simple irritant diaper dermatitis, candidal infections commonly involve the skin folds (picture 7A-E) [1]. There also may be a history of diarrhea, recent antibiotic use, or oral thrush. Diagnosis usually is based on the clinical presentation, but may be confirmed by potassium hydroxide (KOH) preparation demonstrating pseudohyphae or by fungal culture (picture 8A-B).

Persistent candidal diaper rash in young children may be a sign of type 1 diabetes mellitus, chronic mucocutaneous candidiasis, or an underlying immune deficiency. (See "Epidemiology, presentation, and diagnosis of type 1 diabetes mellitus in children and adolescents" and "Chronic mucocutaneous candidiasis", section on 'Clinical features of AIRE deficiency/APECED'.)

Impetigo – Secondary infection from S. aureus and, less frequently, from S. pyogenes also may develop in the diaper region. Hallmarks of impetigo include 1 to 2 mm fragile pustules and honey-colored, crusted erosions. Bullous impetigo describes large, flaccid, pus-filled bullae that tend to rupture easily, leaving erosions with a collarette of scale (picture 9A-B). Gram stain and bacterial culture of a pustule should be performed to confirm the diagnosis. (See "Impetigo".)

Young infants with bacterial diaper dermatitis may require additional evaluation for serious bacterial illness if they are febrile and/or ill-appearing (eg, lethargic, hypotonic, irritable). (See "The febrile infant (29 to 90 days of age): Outpatient evaluation" and "Approach to the ill-appearing infant (younger than 90 days of age)".)

Streptococcal perianal dermatitis – Infants, preschool-, and school-aged children may develop perianal group A streptococcal infection (picture 10A-B) [45,46]. Clinical features include a bright red, sharply demarcated perianal or perineal erythema, sometimes associated with perirectal fissures, blood-streaked stools, pruritus, and pain with defecation [45-49]. Some children present with intermittent episodes of irritability [50]. The patient and/or household contacts may have a history of recurrent streptococcal pharyngitis [48]. Treatment with antibiotics is required.

Herpes simplex virus infection – Herpes simplex virus infection may manifest with vesicular, papular, or pustular lesions in the diaper area. Herpes simplex virus infection in the diaper area is a possible manifestation of child abuse. (See "Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection" and "Evaluation of sexual abuse in children and adolescents".)

EVALUATION — The evaluation of the child with skin inflammation involving the diaper area is focused on determining whether the eruption is a typical irritant contact dermatitis, or the exacerbation of a more diffuse skin disease (eg, seborrheic dermatitis, atopic dermatitis), or the manifestation of unrelated skin conditions that coincidently manifest in the diaper area (table 1) [3,4,51-53]. (See 'Differential diagnosis' below.)

Aspects of the history that can help identify contributing factors and support or exclude non-diaper-associated dermatitis include [11,18,45,54-57]:

Associated symptoms (eg, diarrhea).

Systemic symptoms.

Information about diapers and diapering: type of diaper, how often diapers are changed, method of laundering cloth diapers (if cloth diapers are used).

Information about how the diaper area is cleansed (eg, soaps, cleansers, washcloths, wipes, etc).

Exposure to contagious disease (eg, scabies, herpes simplex virus).

Past history of dermatologic, allergic, or infectious illnesses.

Family history (eg, psoriasis, atopy).

Antibiotic use (predisposes to candidal dermatitis and diarrhea).

Previous therapies that have been used for the diaper dermatitis. It may be helpful to have caregivers bring all of the products being used in the diaper area to the office, since some topical "home remedies" are toxic to infant skin or have the potential for systemic toxicity with percutaneous absorption (eg, boric acid, camphor, phenol, salicylates, and baking soda). (See 'Harmful products' below.)

Laboratory tests are not usually necessary in the evaluation of irritant diaper dermatitis. However, they may help confirm the etiology in atypical or recalcitrant cases [54,55]:

Potassium hydroxide (KOH) preparation and fungal culture of skin scrapings for Candida (picture 8A-B) (see "Clinical manifestations and diagnosis of Candida infection in neonates", section on 'Diagnosis')

Mineral oil slide preparation for scabies (picture 11) (see "Scabies: Epidemiology, clinical features, and diagnosis", section on 'Diagnosis')

Viral culture, polymerase chain reaction (PCR), direct fluorescent antibody (DFA), or Tzanck preparation for the diagnosis of herpes simplex virus (see "Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection", section on 'Diagnosis')

Culture of skin lesions for S. aureus or group A Streptococcus (see "Skin and soft tissue infections in children >28 days: Evaluation and management", section on 'Laboratory evaluation')

A skin biopsy may be necessary in cases in which the rash is atypical or unresponsive to conventional therapy.

DIAGNOSIS — The diagnosis of irritant diaper dermatitis is made clinically, based upon the presence of an erythematous eruption that involves the convex surfaces of buttocks and genital area. The sparing of the skin folds is characteristic of irritant diaper dermatitis, unless there is Candida superinfection.

DIFFERENTIAL DIAGNOSIS — The differential diagnosis of diaper dermatitis is broad and includes:

Seborrheic dermatitis – Seborrheic dermatitis is common during infancy. Clinical features include well-circumscribed erythematous papules and plaques with greasy yellow scale most prominent in the skin folds. In the diaper region, the inguinal creases are mainly involved (picture 12). Seborrheic dermatitis is rarely isolated to the diaper area. Most infants also have involvement of the scalp ("cradle cap"), face, neck, and other skin folds (axillae, antecubital fossa, and popliteal fossa) (picture 13). Seborrheic dermatitis usually responds to short-term topical therapy with low-potency corticosteroids or topical antifungal preparations. (See "Cradle cap and seborrheic dermatitis in infants".)

Atopic dermatitis – Atopic dermatitis usually spares the diaper area, since the diaper provides a moist environment that hydrates the underlying skin, preventing the development of eczematous dermatitis (picture 14). When the diaper area is affected by atopic dermatitis, signs of chronic scratching (eg, increase in skin lines and excoriations) may be observed. Atopic dermatitis usually is present elsewhere on the body, and there is typically a history of pruritus and a family history of atopy. (See "Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis" and "Treatment of atopic dermatitis (eczema)".)

Allergic contact dermatitis – Allergic contact dermatitis is an uncommon cause of dermatitis of the diaper area. Diaper dyes and fragrances appear to be the sensitizing allergens in diapers [55,58]. Preservatives, fragrances, and additives in baby wipes and topical creams have also been implicated [55,59,60]. Heat and moisture associated with diaper use may facilitate allergen release and absorption into the skin. (See "Allergic contact dermatitis in children" and "Management of allergic contact dermatitis in adults".)

Psoriasis – Psoriasis can appear at any age and may initially develop in the diaper area [61]. It usually presents with sharply demarcated, erythematous, scaly papules and plaques in the diaper area (picture 15A-B). Significant scale may be lacking in involved areas in the diaper region due to the presence of maceration and moisture beneath the diaper. There may be a family history of psoriasis, and erythematous plaques with scale may also be noted elsewhere on the body. (See "Psoriasis in children: Epidemiology, clinical manifestations, and diagnosis".)

Scabies – Scabies can involve the diaper region in infants (picture 16). An acute, widespread, pruritic dermatitis is the most common manifestation. Cutaneous findings include a widespread vesiculopapular eruption involving the trunk (picture 17), axillae (picture 18), neck, palms, and soles (picture 19). Other family members with similar lesions and a history of pruritus support the diagnosis. Diagnosis is confirmed by identifying a mite, egg, or stool on microscopic examination of a scraping from a lesion (picture 11). The diagnosis and treatment of scabies is discussed in detail separately. (See "Scabies: Epidemiology, clinical features, and diagnosis".)

Langerhans cell histiocytosis – Langerhans cell histiocytosis (LCH) is a potentially life-threatening hematologic/oncologic disorder that can present with severe or recalcitrant diaper dermatitis. The cutaneous lesions usually present during infancy or early childhood and consist of red/orange or yellow/brown scaly papules, erosions, or petechiae most commonly in the groin, intertriginous regions, and scalp (picture 20A-B).

LCH can resemble seborrheic dermatitis; however, the color of the lesions and presence of petechiae and erosions helps to differentiate between the two. In addition to the cutaneous findings, patients with LCH also may have bone lesions, lymphadenopathy, hepatosplenomegaly, and anemia. Skin biopsy is necessary to confirm the diagnosis. (See "Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis".)

Child abuse – Child abuse is an important consideration in severe, recalcitrant, or atypical diaper dermatitis. A severe diaper dermatitis that appears "resistant" to treatment may actually be the result of neglect by the parent or caregiver. The diaper area also is a possible site for scalds, burns, and bruises in abused children. Although infection with the human papilloma virus (condyloma acuminatum or genital warts) in the groin region can be acquired perinatally from an infected mother, sexual abuse also should be considered and addressed as a possible underlying cause. (See "Child neglect: Evaluation and management" and "Physical child abuse: Recognition" and "Evaluation of sexual abuse in children and adolescents", section on 'Suspicious findings'.)

Congenital syphilis – The skin lesions of congenital syphilis may be present at or after birth [1,9]. They may be seen in the diaper area and/or around the mouth and nose and are characteristically copper-colored, scaly macules and papules or moist erosions (picture 21); perianal papular lesions (condyloma lata) also may be seen. The skin lesions contain spirochetes and are highly infectious. Other manifestations of congenital syphilis include symmetric desquamation of the palms and soles, anemia, hepatosplenomegaly, jaundice, and changes of the long bones. The diagnosis is confirmed with serology or dark field microscopy, if available. (See "Congenital syphilis: Clinical manifestations, evaluation, and diagnosis", section on 'Clinical findings'.)

Other – Rarely, nutritional deficiencies and immunodeficiencies can present with recalcitrant diaper dermatitis. These include acrodermatitis enteropathica (zinc deficiency (picture 22)), biotin deficiency, and cystic fibrosis (secondary to malabsorption) as well as many other uncommon disorders [1,4,62,63].

MANAGEMENT — In most cases, the management of diaper dermatitis involves general skin care measures (eg, frequent diaper changing, air exposure, gentle cleansing), choice of diapers, and use of topical barrier preparations [2]. Low-potency topical corticosteroids and antifungals may be used in severe cases and in cases complicated by Candida superinfection.

Skin care of the diaper area — Increasing the frequency of diaper changing and skin cleansing limits prolonged skin contact with stool and urine and therefore is an essential aspect of the management of diaper dermatitis [1,12]. If possible, an infant with irritant diaper dermatitis should be allowed periods of rest without a diaper (eg, a few hours per day), allowing the skin to be exposed directly to air [2,3].

The diaper area should be gently cleaned with warm water and a small amount of a mild cleansing product with physiologic pH. (See 'Prevention' below.)

As an alternative, fragrance-free and alcohol-free baby wipes can be used, but should be discontinued if the skin becomes irritated or broken down. Preservatives such as methylisothiazolinone in baby wipes may cause allergic contact dermatitis [60]. (See 'Differential diagnosis' above and "Common allergens in allergic contact dermatitis", section on 'Isothiazolinones'.)

Choice of diaper — The best choice of diapers for use in infants is a controversial issue. A systematic review of studies evaluating whether disposable diapers prevent diaper dermatitis in children concluded that there was not enough evidence from good-quality, randomized controlled trials to support or refute the use and type of disposable diapers to prevent diaper dermatitis in infants [64]. (See 'Prevention' below.)

Topical therapies

Barrier preparations — Barrier preparations physically block chemical irritants and moisture from contacting the skin and minimize friction [19,65]. Pastes and ointments generally are better barriers than creams and lotions, which are poorly adherent, minimally occlusive, and may contain fragrances and preservatives [19,65].

The use of topical barrier ointments and pastes for the treatment of diaper dermatitis is based upon long-standing clinical experience. There are a few poor-quality randomized trials comparing these agents to placebo or to one another [65,66].

The most common over-the-counter topical barriers contain petrolatum, zinc oxide, or both [1,18,21,45]. Some also contain lanolin, paraffin, or dimethicone (a silicone oil) [45].

Sucralfate, a prescription medication labeled for the treatment of duodenal ulcers in the United States, also acts as a physical barrier to irritants and has antibacterial activity. Topical application of sucralfate has been reported to be useful in the management of severe or recalcitrant irritant diaper dermatitis [67].

Topical corticosteroids — A low-potency topical corticosteroid (table 2) can reduce the inflammation in diaper dermatitis that persists despite skin care measures and use of barrier preparations. (See 'Severe diaper dermatitis' below.)

The use of topical corticosteroids for diaper dermatitis has not been evaluated in randomized trials. Their use is based upon evidence of efficacy in other childhood inflammatory skin conditions and clinical experience. Potent or fluorinated corticosteroids should not be used in the diaper since the occlusion in the area promotes systemic absorption and may cause adrenal suppression and iatrogenic Cushing syndrome [68-73]. (See "Topical corticosteroids: Use and adverse effects", section on 'Use in children'.)

Antifungal agents — Antifungal agents, such as nystatin, clotrimazole, miconazole, ketoconazole, and sertaconazole, are effective topical therapies for diaper dermatitis complicated by secondary Candida infection [74-78]. They are typically applied twice daily for two weeks.

In a randomized trial, an antifungal paste containing clotrimazole was found to be superior to one with nystatin with respect to reduction in symptom score and global assessment of diaper dermatitis in infants; both treatments were applied twice daily for two weeks [79]. However, microbiologic cure was achieved in 100 percent of cases with both agents.

Potential adverse effects of antifungals include irritation, burning, and itching.

Other — Breast milk is thought to have anti-inflammatory and antimicrobial properties. In one study including 150 infants with mild to moderate diaper dermatitis, breast milk was as effective as 1% hydrocortisone cream in clearing the rash after seven days of treatment [80].

Another study compared breast milk with a zinc oxide-containing barrier cream in the treatment of moderate to severe diaper dermatitis in infants in the neonatal intensive care unit [81]. The time to improvement was similar in the two groups, although the clinical score was lower in the barrier cream group.

Harmful products — Use of powders such as cornstarch or talcum powder pose a significant respiratory risk if accidentally aspirated and therefore should be avoided [45,82]. Baking soda and boric acid powders also should be avoided because of the risk of systemic toxicity with percutaneous absorption [18,45,83,84].

Topical barriers or medications that contain fragrance, preservatives, and other ingredients with irritant or allergic potential (eg, neomycin) should be avoided [65]. Products containing boric acid, camphor, phenol, benzocaine, and salicylates also should be avoided because of the potential for systemic toxicity and/or methemoglobinemia [18,44,65,83,85-88]. These agents are contained in some commercially available products for diaper dermatitis. (See "Methemoglobinemia", section on 'Acquired causes'.)

Approach to treatment

Mild to moderate diaper dermatitis — We suggest topical barrier preparations in the form of creams, ointments, or pastes as the first-line therapy for mild to moderate diaper dermatitis [18,65]. Topical barriers are applied with every diaper change; they should be applied thickly and can be covered with petroleum jelly to prevent sticking to the diaper [89].

Severe diaper dermatitis — We suggest low-potency, nonhalogenated topical corticosteroids (Group 7, (table 2)) such as 1% hydrocortisone for the treatment of severely inflamed irritant diaper dermatitis that does not respond to barrier products alone. Topical corticosteroids are applied twice a day for three to seven days concomitantly with barrier ointments [1,5,9,19,21]. Barrier products should be applied last.

Candida superinfection — We suggest antifungal agents for the treatment of diaper dermatitis in the following situations:

There is clinical evidence of Candida superinfection (eg, beefy red plaques, satellite papules, superficial pustules, involvement of the skin folds) (picture 7C, 7E).

Candida superinfection has been confirmed by potassium hydroxide (KOH) preparation or fungal culture (picture 8A-B).

The dermatitis has been present for at least three days (which increases the likelihood of secondary infection with Candida).

Antifungal creams or ointments are applied to the diaper area beneath the barrier ointment two to three times a day until the rash has resolved.

Combination topical corticosteroids and antifungal creams such as betamethasone dipropionate and clotrimazole cream or triamcinolone acetonide and nystatin cream should not be used in the diaper area [6,7,90-92]. Both contain topical corticosteroids that are too potent for infant skin and may cause unwanted corticosteroid side effects such as skin atrophy and adrenal suppression [6,91]. These combination creams also have been found to provide only temporary improvement [90,91].

Bacterial superinfection — If a secondary bacterial infection is present, topical or oral antibiotics may be necessary. If the bacterial infection is localized and mild, topical mupirocin applied twice a day for five to seven days may be sufficient to treat a staphylococcal infection. Oral antibiotics are indicated for more severe infections, including perianal streptococcal dermatitis [1,20,93]. (See 'Secondary infection' above.)

Neosporin ointment should not be used because it contains neomycin, a common inciting allergen for allergic contact dermatitis. Similarly, bacitracin ointment should be avoided. (See "Common allergens in allergic contact dermatitis", section on 'Antibiotics'.)

Young infants with bacterial diaper dermatitis may require additional evaluation for serious bacterial illness, especially if they are febrile and/or ill-appearing (eg, lethargic, hypotonic, irritable). Such infants usually require hospital admission and initial therapy with parenteral antibiotics [93]. (See "The febrile infant (29 to 90 days of age): Outpatient evaluation" and "Approach to the ill-appearing infant (younger than 90 days of age)".)

Refractory diaper dermatitis — In children with recalcitrant diaper rash that does not resolve with standard treatment, non-diaper-associated causes of dermatitis or underlying conditions that predispose to diaper dermatitis must be considered [45]. Additional laboratory testing or a skin biopsy may be required for precise diagnosis. (See 'Differential diagnosis' above.)

Among non-diaper-associated causes of dermatitis, Langerhans cell histiocytosis, infections, nutritional deficiencies, and child abuse or neglect are particularly important to remember. (See 'Evaluation' above.)

Persistent candidal diaper rash in young children may be a sign of type 1 diabetes mellitus, chronic mucocutaneous candidiasis, or an underlying immune deficiency. (See "Epidemiology, presentation, and diagnosis of type 1 diabetes mellitus in children and adolescents" and "Chronic mucocutaneous candidiasis", section on 'Clinical features of AIRE deficiency/APECED'.)

PREVENTION — There are no randomized trials evaluating the efficacy of specific skin care practices, including the use of barrier ointments, in the prevention of diaper dermatitis [94]. Based upon clinical experience, the most effective way to prevent irritant diaper dermatitis is to minimize direct skin contact with urine and feces by frequent diaper change and gentle cleansing of the diaper area [1,12,28,94-96]:

Type of diaper – Although there is significant debate about the environmental impact of disposable versus cloth diapers, disposable diapers have been designed specifically to mitigate factors that predispose to irritant diaper dermatitis [97-100]. Disposable diapers have an absorbent gel core that can absorb up to 80 times its weight in water and outer layers that absorb liquids quickly and prevent liquid from leaking back out of the diaper on the skin [98-100]. However, a systematic review of studies evaluating whether disposable diapers prevent diaper dermatitis in children concluded that there was not enough evidence from good-quality randomized trials to support or refute the use and type of disposable diapers to prevent diaper dermatitis in infants [64]. Whether parents/caregivers choose to use cloth or disposable diapers, frequent diaper changes help prevent irritant diaper dermatitis. During treatment of diaper dermatitis, disposable diapers may be preferred.

Cleansing – Overzealous cleansing can promote irritation and delay skin healing. Limited gentle cleansing with warm water and a soft cloth usually is sufficient [1]. If soaps are desired, mild fragrance-free liquid soaps may be used. If the diaper area is eroded, it may be irrigated with water from a plastic squeeze bottle or by squeezing a washcloth soaked in water [45,101]. Dried feces can be gently removed with mineral oil applied to a cotton ball [101]. It is not necessary to wipe off barrier paste completely at each diaper change, but when removal is required, mineral oil is helpful [45,65,89,101,102]. To avoid unnecessary friction, the diaper area should be dried by gently patting with a towel [45,65].

Fragrance-free and alcohol-free baby wipes can be used as an alternative to water and cloth but should be discontinued if the skin becomes irritated or broken down. Infant wipes are widely used for practical reasons, although there is limited evidence from randomized trials that they are gentler than water for cleansing the diaper area [103-105]. Baby wipes containing the preservative methylisothiazolinone may cause allergic sensitization and should be avoided [60].

In a randomized trial including 280 healthy newborns, alcohol-free baby wipes were comparable to cotton wool and water in terms of skin hydration, skin surface pH, transepidermal water loss (TEWL), and density of microbial skin contaminants [103]. In a randomized study comparing wipes with water and cloth for skin cleansing in preterm and term neonatal intensive care unit (NICU) newborns, skin erythema, pH, and TEWL were lower in the wipes group than in the water and cloth group [104].

The United States Association of Women's Health, Obstetric and Neonatal Nurses recommend that detergent- and alcohol-free wipes may be used if a clean cloth and water are not available [106].

Education – Educating parents and caregivers in ways of preventing and treating diaper dermatitis is of utmost importance. Providing educational materials/handouts can be helpful since it allows families/caregivers to review the information again at home.

SOCIETY GUIDELINE LINKS — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Diaper dermatitis".)

INFORMATION FOR PATIENTS — UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.

Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)

Basics topics (see "Patient education: Diaper rash (The Basics)" and "Patient education: Giving your child over-the-counter medicines (The Basics)")

Beyond the Basics topics (see "Patient education: Diaper rash in infants and children (Beyond the Basics)")

SUMMARY AND RECOMMENDATIONS

Etiology and risk factors – Diaper dermatitis, also called napkin dermatitis or nappy rash, is a common form of irritant contact dermatitis due, in most cases, to prolonged contact of the skin with urine and stool, resulting in disruption of the stratum corneum and inflammation. Infrequent diaper changing, diarrhea, dietary factors, and recent use of antibiotics are the main risk factors for diaper dermatitis. However, eruptions in the diaper area may be the manifestation of unrelated skin conditions, which coincidently manifest in the diaper area (table 1). (See 'Introduction' above and 'Pathogenesis' above.)

Clinical presentation – Characteristic features of irritant diaper dermatitis include involvement of the convex surfaces and sparing of the skin folds (picture 1A), unless there is Candida superinfection (picture 7E). The lesions may vary from asymptomatic erythema to painful scaling papules and superficial erosions (picture 3A). Rare presentations of severe, chronic, irritant diaper dermatitis include Jacquet's erosive diaper dermatitis (picture 4), granuloma gluteale infantum (picture 5), and pseudoverrucous papules and nodules (picture 6). (See 'Clinical features' above.)

Diagnosis – The diagnosis of irritant diaper dermatitis is clinical, based upon the presence of an erythematous eruption that involves the convex surfaces of the diaper area and spares the folds. Atypical-appearing diaper rashes and those that fail to resolve with conventional treatment warrant additional evaluation. (See 'Diagnosis' above and 'Differential diagnosis' above.)

Management General measures for the management of diaper dermatitis include frequent diaper changing, air exposure, and gentle skin cleansing:

We suggest topical barrier ointments or creams as the first-line treatment for mild to moderate diaper dermatitis (Grade 2C). We suggest the addition of low-potency nonhalogenated topical corticosteroids such as 1% hydrocortisone for severely inflamed irritant diaper dermatitis (Grade 2C). (See 'Mild to moderate diaper dermatitis' above and 'Severe diaper dermatitis' above.)

We suggest the addition of a topical antifungal agent in children in whom the diaper dermatitis appears to be or is confirmed to be complicated by Candida superinfection, or in whom the dermatitis has been present for at least three days (Grade 2B). We do not use combination topical corticosteroids and antifungal creams for the treatment of irritant diaper dermatitis. Most available combination creams contain topical corticosteroids that are too potent for infant skin and may cause unwanted corticosteroid side effects, such as skin atrophy and adrenal suppression. (See 'Candida superinfection' above.)

Powders (eg, cornstarch, talcum powder) pose a significant respiratory risk if accidentally aspirated and should be avoided. (See 'Harmful products' above.)

ACKNOWLEDGMENT — The UpToDate editorial staff acknowledges Trisha A Prossick, MD, who contributed to an earlier version of this topic review.

  1. Arnsmeier SL, Paller AS. Getting to the bottom of diaper dermatitis. Contemporary Pediatr 1997; 14:115.
  2. Shin HT. Diagnosis and management of diaper dermatitis. Pediatr Clin North Am 2014; 61:367.
  3. Klunk C, Domingues E, Wiss K. An update on diaper dermatitis. Clin Dermatol 2014; 32:477.
  4. Krol AL, Krafchik BR. Diaper area eruptions. In: Neonatal and Infant Dermatology, 3rd ed, Eichenfield LF, Frieden IJ, Mather EF, Zaenglein AL (Eds), Elsevier Saunders, 2015.
  5. Levy M. Diaper rash syndrome or dermatitis. Cutis 2001; 67:37.
  6. Ward DB, Fleischer AB Jr, Feldman SR, Krowchuk DP. Characterization of diaper dermatitis in the United States. Arch Pediatr Adolesc Med 2000; 154:943.
  7. Scheinfeld N. Diaper dermatitis: a review and brief survey of eruptions of the diaper area. Am J Clin Dermatol 2005; 6:273.
  8. Thaman LA, Eichenfield LF. Diapering habits: a global perspective. Pediatr Dermatol 2014; 31 Suppl 1:15.
  9. Coughlin CC, Eichenfield LF, Frieden IJ. Diaper dermatitis: clinical characteristics and differential diagnosis. Pediatr Dermatol 2014; 31 Suppl 1:19.
  10. Li CH, Zhu ZH, Dai YH. Diaper dermatitis: a survey of risk factors for children aged 1-24 months in China. J Int Med Res 2012; 40:1752.
  11. Sukhneewat C, Chaiyarit J, Techasatian L. Diaper dermatitis: a survey of risk factors in Thai children aged under 24 months. BMC Dermatol 2019; 19:7.
  12. Jordan WE, Lawson KD, Berg RW, et al. Diaper dermatitis: frequency and severity among a general infant population. Pediatr Dermatol 1986; 3:198.
  13. Nield LS, Kamat D. Prevention, diagnosis, and management of diaper dermatitis. Clin Pediatr (Phila) 2007; 46:480.
  14. Stamatas GN, Zerweck C, Grove G, Martin KM. Documentation of impaired epidermal barrier in mild and moderate diaper dermatitis in vivo using noninvasive methods. Pediatr Dermatol 2011; 28:99.
  15. Stamatas GN, Tierney NK. Diaper dermatitis: etiology, manifestations, prevention, and management. Pediatr Dermatol 2014; 31:1.
  16. Atherton DJ. Understanding irritant napkin dermatitis. Int J Dermatol 2016; 55 Suppl 1:7.
  17. Ali SM, Yosipovitch G. Skin pH: from basic science to basic skin care. Acta Derm Venereol 2013; 93:261.
  18. Boiko S. Treatment of diaper dermatitis. Dermatol Clin 1999; 17:235.
  19. Atherton DJ. A review of the pathophysiology, prevention and treatment of irritant diaper dermatitis. Curr Med Res Opin 2004; 20:645.
  20. Kazaks EL, Lane AT. Diaper dermatitis. Pediatr Clin North Am 2000; 47:909.
  21. Wolf R, Wolf D, Tüzün B, Tüzün Y. Diaper dermatitis. Clin Dermatol 2000; 18:657.
  22. Berg RW, Milligan MC, Sarbaugh FC. Association of skin wetness and pH with diaper dermatitis. Pediatr Dermatol 1994; 11:18.
  23. Ferrazzini G, Kaiser RR, Hirsig Cheng SK, et al. Microbiological aspects of diaper dermatitis. Dermatology 2003; 206:136.
  24. Berg RW, Buckingham KW, Stewart RL. Etiologic factors in diaper dermatitis: the role of urine. Pediatr Dermatol 1986; 3:102.
  25. Buckingham KW, Berg RW. Etiologic factors in diaper dermatitis: the role of feces. Pediatr Dermatol 1986; 3:107.
  26. Ersoy-Evans S, Akıncı H, Doğan S, Atakan N. Diaper Dermatitis: A Review of 63 Children. Pediatr Dermatol 2016; 33:332.
  27. Adalat S, Wall D, Goodyear H. Diaper dermatitis-frequency and contributory factors in hospital attending children. Pediatr Dermatol 2007; 24:483.
  28. Lim YSL, Carville K. Prevention and Management of Incontinence-Associated Dermatitis in the Pediatric Population: An Integrative Review. J Wound Ostomy Continence Nurs 2019; 46:30.
  29. Honig PJ, Gribetz B, Leyden JJ, et al. Amoxicillin and diaper dermatitis. J Am Acad Dermatol 1988; 19:275.
  30. Koblenzer PJ. Diaper dermatitis--an overview with emphasis on rational therapy based on etiology and pathodynamics. Clin Pediatr (Phila) 1973; 12:386.
  31. Robson KJ, Maughan JA, Purcell SD, et al. Erosive papulonodular dermatosis associated with topical benzocaine: a report of two cases and evidence that granuloma gluteale, pseudoverrucous papules, and Jacquet's erosive dermatitis are a disease spectrum. J Am Acad Dermatol 2006; 55:S74.
  32. Paradisi A, Capizzi R, Ghitti F, et al. Jacquet erosive diaper dermatitis: a therapeutic challenge. Clin Exp Dermatol 2009; 34:e385.
  33. Bluestein J, Furner BB, Phillips D. Granuloma gluteale infantum: case report and review of the literature. Pediatr Dermatol 1990; 7:196.
  34. Ramos Pinheiro R, Matos-Pires E, Baptista J, Lencastre A. Granuloma Glutaeale Infantum: A Re-emerging Complication of Diaper Dermatitis. Pediatrics 2018; 141.
  35. Dytoc MT, Fiorillo L, Liao J, Krol AL. Granuloma gluteale adultorum associated with use of topical benzocaine preparations: case report and literature review. J Cutan Med Surg 2002; 6:221.
  36. Garrido-Ruiz MC, Rosales B, Luis Rodríguez-Peralto J. Vulvar pseudoverrucous papules and nodules secondary to a urethral--vaginal fistula. Am J Dermatopathol 2011; 33:410.
  37. Borglund E, Nordström G, Nyman CR. Classification of peristomal skin changes in patients with urostomy. J Am Acad Dermatol 1988; 19:623.
  38. Dixit S, Scurry JP, Fischer G. A vesicular variant of pseudoverrucous papules and nodules in the genital area of an incontinent 4-year-old. Australas J Dermatol 2013; 54:e92.
  39. Dandale A, Dhurat R, Ghate S. Perianal pseudoverrucous papules and nodules. Indian J Sex Transm Dis 2013; 34:44.
  40. Coppo P, Salomone R. Pseudoverrucous papules: an aspect of incontinence in children. J Eur Acad Dermatol Venereol 2002; 16:409.
  41. Goldberg NS, Esterly NB, Rothman KF, et al. Perianal pseudoverrucous papules and nodules in children. Arch Dermatol 1992; 128:240.
  42. Maruani A, Lorette G, Barbarot S, et al. Re-emergence of papulonodular napkin dermatitis with use of reusable diapers: report of 5 cases. Eur J Dermatol 2013; 23:246.
  43. Harfmann K, Chen AY, Witman P. Bullous diaper dermatitis with cloth diaper use. Pediatr Dermatol 2017; 34:e309.
  44. Weston WL, Lane AT, Weston JA. Diaper dermatitis: current concepts. Pediatrics 1980; 66:532.
  45. Shin HT. Diaper dermatitis that does not quit. Dermatol Ther 2005; 18:124.
  46. Brilliant LC. Perianal streptococcal dermatitis. Am Fam Physician 2000; 61:391.
  47. Kokx NP, Comstock JA, Facklam RR. Streptococcal perianal disease in children. Pediatrics 1987; 80:659.
  48. Barzilai A, Choen HA. Isolation of group A streptococci from children with perianal cellulitis and from their siblings. Pediatr Infect Dis J 1998; 17:358.
  49. Clegg HW, Giftos PM, Anderson WE, et al. Clinical Perineal Streptococcal Infection in Children: Epidemiologic Features, Low Symptomatic Recurrence Rate after Treatment, and Risk Factors for Recurrence. J Pediatr 2015; 167:687.
  50. Van Gysel D. Infections and skin diseases mimicking diaper dermatitis. Int J Dermatol 2016; 55 Suppl 1:10.
  51. Tüzün Y, Wolf R, Bağlam S, Engin B. Diaper (napkin) dermatitis: A fold (intertriginous) dermatosis. Clin Dermatol 2015; 33:477.
  52. Cohen B. Differential Diagnosis of Diaper Dermatitis. Clin Pediatr (Phila) 2017; 56:16S.
  53. Fölster-Holst R. Differential diagnoses of diaper dermatitis. Pediatr Dermatol 2018; 35 Suppl 1:s10.
  54. Liptak GS. Diaper rash. In: Primary Pediatric Care, 4th ed, Hoekelman RA (Ed), Mosby, 2001. p.1457.
  55. Yu J, Treat J, Chaney K, Brod B. Potential Allergens in Disposable Diaper Wipes, Topical Diaper Preparations, and Disposable Diapers: Under-recognized Etiology of Pediatric Perineal Dermatitis. Dermatitis 2016; 27:110.
  56. Blume-Peytavi U, Kanti V. Prevention and treatment of diaper dermatitis. Pediatr Dermatol 2018; 35 Suppl 1:s19.
  57. Burdall O, Willgress L, Goad N. Neonatal skin care: Developments in care to maintain neonatal barrier function and prevention of diaper dermatitis. Pediatr Dermatol 2019; 36:31.
  58. Jacob SE, Herro EM, Guide S, et al. Allergic contact dermatitis to Pampers Drymax. Pediatr Dermatol 2012; 29:672.
  59. Smith WJ, Jacob SE. The role of allergic contact dermatitis in diaper dermatitis. Pediatr Dermatol 2009; 26:369.
  60. Chang MW, Nakrani R. Six children with allergic contact dermatitis to methylisothiazolinone in wet wipes (baby wipes). Pediatrics 2014; 133:e434.
  61. Watanabe M, Tabata N, Tagami H. Explosive diaper pustular psoriasis. Pediatr Dermatol 2002; 19:564.
  62. Darmstadt GL, Schmidt CP, Wechsler DS, et al. Dermatitis as a presenting sign of cystic fibrosis. Arch Dermatol 1992; 128:1358.
  63. Higuchi R, Mizukoshi M, Koyama H, et al. Intractable diaper dermatitis as an early sign of biotin deficiency. Acta Paediatr 1998; 87:228.
  64. Baer EL, Davies MW, Easterbrook KJ. Disposable nappies for preventing napkin dermatitis in infants. Cochrane Database Syst Rev 2006; :CD004262.
  65. Humphrey S, Bergman JN, Au S. Practical management strategies for diaper dermatitis. Skin Therapy Lett 2006; 11:1.
  66. Davies MW, Dore AJ, Perissinotto KL. Topical vitamin A, or its derivatives, for treating and preventing napkin dermatitis in infants. Cochrane Database Syst Rev 2005; :CD004300.
  67. Markham T, Kennedy F, Collins P. Topical sucralfate for erosive irritant diaper dermatitis. Arch Dermatol 2000; 136:1199.
  68. Semiz S, Balci YI, Ergin S, et al. Two cases of Cushing's syndrome due to overuse of topical steroid in the diaper area. Pediatr Dermatol 2008; 25:544.
  69. Ozon A, Cetinkaya S, Alikasifoglu A, et al. Inappropriate use of potent topical glucocorticoids in infants. J Pediatr Endocrinol Metab 2007; 20:219.
  70. Buluş AD, Andıran N, Koçak M. Cushing's syndrome: hidden risk in usage of topical corticosteroids. J Pediatr Endocrinol Metab 2014; 27:977.
  71. Tempark T, Phatarakijnirund V, Chatproedprai S, et al. Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature. Endocrine 2010; 38:328.
  72. Jevalikar G, Sharma O. Exogenous Cushing Syndrome due to Topical Clobetasone use for Diaper Rash. Indian Pediatr 2016; 53:76.
  73. Özgüç Çömlek F, Örüm S, Aydın S, Tütüncüler F. Exogenous Cushing syndrome due to misuse of potent topical steroid. Pediatr Dermatol 2018; 35:e121.
  74. Spraker MK, Gisoldi EM, Siegfried EC, et al. Topical miconazole nitrate ointment in the treatment of diaper dermatitis complicated by candidiasis. Cutis 2006; 77:113.
  75. Eichenfield LF, Bogen ML. Absorption and efficacy of miconazole nitrate 0.25% ointment in infants with diaper dermatitis. J Drugs Dermatol 2007; 6:522.
  76. Bonifaz A, Tirado-Sánchez A, Graniel MJ, et al. The efficacy and safety of sertaconazole cream (2 %) in diaper dermatitis candidiasis. Mycopathologia 2013; 175:249.
  77. Concannon P, Gisoldi E, Phillips S, Grossman R. Diaper dermatitis: a therapeutic dilemma. Results of a double-blind placebo controlled trial of miconazole nitrate 0.25%. Pediatr Dermatol 2001; 18:149.
  78. Taudorf EH, Jemec GBE, Hay RJ, Saunte DML. Cutaneous candidiasis - an evidence-based review of topical and systemic treatments to inform clinical practice. J Eur Acad Dermatol Venereol 2019; 33:1863.
  79. Hoeger PH, Stark S, Jost G. Efficacy and safety of two different antifungal pastes in infants with diaper dermatitis: a randomized, controlled study. J Eur Acad Dermatol Venereol 2010; 24:1094.
  80. Farahani LA, Ghobadzadeh M, Yousefi P. Comparison of the effect of human milk and topical hydrocortisone 1% on diaper dermatitis. Pediatr Dermatol 2013; 30:725.
  81. Gozen D, Caglar S, Bayraktar S, Atici F. Diaper dermatitis care of newborns human breast milk or barrier cream. J Clin Nurs 2014; 23:515.
  82. Silver P, Sagy M, Rubin L. Respiratory failure from corn starch aspiration: a hazard of diaper changing. Pediatr Emerg Care 1996; 12:108.
  83. Deadly diapers. Br Med J 1970; 2:314.
  84. Gonzalez J, Hogg RJ. Metabolic alkalosis secondary to baking soda treatment of a diaper rash. Pediatrics 1981; 67:820.
  85. Farrington E. Diaper dermatitis. Pediatr Nurs 1992; 18:81.
  86. Morra P, Bartle WR, Walker SE, et al. Serum concentrations of salicylic acid following topically applied salicylate derivatives. Ann Pharmacother 1996; 30:935.
  87. Jensen JP. [Transcutaneous absorption of boron from a baby ointment used prophylactically against diaper dermatitis]. Nord Med 1971; 86:1425.
  88. Tush GM, Kuhn RJ. Methemoglobinemia induced by an over-the-counter medication. Ann Pharmacother 1996; 30:1251.
  89. Borkowski S. Diaper rash care and management. Pediatr Nurs 2004; 30:467.
  90. Alston SJ, Cohen BA, Braun M. Persistent and recurrent tinea corporis in children treated with combination antifungal/ corticosteroid agents. Pediatrics 2003; 111:201.
  91. Greenberg HL, Shwayder TA, Bieszk N, Fivenson DP. Clotrimazole/betamethasone diproprionate: a review of costs and complications in the treatment of common cutaneous fungal infections. Pediatr Dermatol 2002; 19:78.
  92. Wheat CM, Bickley RJ, Hsueh YH, Cohen BA. Current Trends in the Use of Two Combination Antifungal/Corticosteroid Creams. J Pediatr 2017; 186:192.
  93. Fortunov RM, Hulten KG, Hammerman WA, et al. Evaluation and treatment of community-acquired Staphylococcus aureus infections in term and late-preterm previously healthy neonates. Pediatrics 2007; 120:937.
  94. Blume-Peytavi U, Hauser M, Lünnemann L, et al. Prevention of diaper dermatitis in infants--a literature review. Pediatr Dermatol 2014; 31:413.
  95. Ravanfar P, Wallace JS, Pace NC. Diaper dermatitis: a review and update. Curr Opin Pediatr 2012; 24:472.
  96. Merrill L. Prevention, Treatment and Parent Education for Diaper Dermatitis. Nurs Womens Health 2015; 19:324.
  97. Odio M, Thaman L. Diapering, diaper technology, and diaper area skin health. Pediatr Dermatol 2014; 31 Suppl 1:9.
  98. Helmes CT, O'Connor R, Sawyer L, Young S. Disposable Diaper Absorbency: Improvements via Advanced Designs. Clin Pediatr (Phila) 2014; 53:14S.
  99. Counts JL, Helmes CT, Kenneally D, Otts DR. Modern Disposable Diaper Construction: Innovations in Performance Help Maintain Healthy Diapered Skin. Clin Pediatr (Phila) 2014; 53:10S.
  100. Counts J, Weisbrod A, Yin S. Common Diaper Ingredient Questions: Modern Disposable Diaper Materials Are Safe and Extensively Tested. Clin Pediatr (Phila) 2017; 56:23S.
  101. Boiko S. Making rash decisions in the diaper area. Pediatr Ann 2000; 29:50.
  102. Darmstadt GL, Dinulos JG. Neonatal skin care. Pediatr Clin North Am 2000; 47:757.
  103. Lavender T, Furber C, Campbell M, et al. Effect on skin hydration of using baby wipes to clean the napkin area of newborn babies: assessor-blinded randomised controlled equivalence trial. BMC Pediatr 2012; 12:59.
  104. Visscher M, Odio M, Taylor T, et al. Skin care in the NICU patient: effects of wipes versus cloth and water on stratum corneum integrity. Neonatology 2009; 96:226.
  105. Coughlin CC, Frieden IJ, Eichenfield LF. Clinical approaches to skin cleansing of the diaper area: practice and challenges. Pediatr Dermatol 2014; 31 Suppl 1:1.
  106. Association of Women's Health, Obstetric, and Neonatal Nurses. Neonatal Skin Care Evidence-Based Clinical Practice Guideline, 3rd ed, 2013.
Topic 5795 Version 24.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟